Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Primary Completion Date

March 31, 2002

Study Completion Date

March 31, 2002

Conditions
Breast Cancer
Interventions
DRUG

letrozole

Trial Locations (20)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

33020

Cancer Research Network, Inc., Hollywood

33156

Pharm Research, Pinecrest

33176

Oncology-Hematology Group of South Florida, Miami

33324

Cancer Research Network Inc., Plantation

33401

Good Samaritan Medical Center, West Palm Beach

37205

Dial Research Associates, Inc., Nashville

38119

Memphis Cancer Center, Memphis

45238

Oncology Partnership Network, Cincinnati

60435

Joliet Oncology/Hematology Associates, Ltd., Joliet

61801

Carle Cancer Center, Urbana

62221

Illinois Oncology, Ltd., Belleville

62781

Memorial Medical Center, Springfield

70503

Southwest Oncology Association, Lafayette

75230

Center for Oncology Research and Treatment, Medical City Hospital, Dallas

84124

Intermountain Hematology/Oncology Associates, Inc., Salt Lake City

87109

New Mexico Oncology-Hematology, Albuquerque

90806

Long Beach Memorial Breast Center, Long Beach

94704

Alta Bates Comprehensive Cancer Center, Berkeley

98034-3013

Cascade Cancer Center, Kirkland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00014638 - Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter